✦ LIBER ✦

Efficacy of bedelix® a therapeutic clay, in patients with irritable bowel syndrome: A placebo controlled double blind study

✍ Scribed by Ducrotte, Philippe; Dapoigny, Michel; Bonaz, Bruno; Siproudhis, Laurent

Book ID: 123355294
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 233 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)81974-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Melatonin improves bowel symptoms in fem

Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study

✍ W. Z. LU; K. A. GWEE; S. MOOCHHALLA; K. Y. HO 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Efficacy of drotaverine in irritable bow

Efficacy of drotaverine in irritable bowel syndrome: a double blind, randomized, placebo-controlled clinical trial

✍ Sharat C Misra; Ravindra M Pandey 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 58 KB

A double-blind placebo-controlled trial

A double-blind placebo-controlled trial to study therapeutic effects of probioticEscherichia coliNissle 1917 in subgroups of patients with irritable bowel syndrome

✍ Wolfgang Kruis; Sigrun Chrubasik; Stephan Boehm; Christiane Stange; Juergen Schu 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 200 KB

Acute exacerbation of pain in irritable

Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol – a randomized, double-blind, placebo-controlled study

✍ O. CHASSANY; B. BONAZ; S. BRULEY DES VARANNES; L. BUENO; G. CARGILL; B. COFFIN; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

A Double-Blind, Randomized, Placebo-Cont

A Double-Blind, Randomized, Placebo-Controlled Trial of Paroxetine Controlled-Release in Irritable Bowel Syndrome

✍ Prakash S. Masand; Chi-Un Pae; Stan Krulewicz; Kathleen Peindl; Paolo Mannelli; 📂 Article 📅 2009 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 141 KB

The efficacy of Lactobacillus reuteri AT

The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome—a double blind, placebo-controlled, randomized study

✍ Eva Niv; Timna Naftali; Ron Hallak; Nachum Vaisman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 172 KB